ONTOLOGY REPORT - ANNOTATIONS
| Term: | 2,6-di-tert-butyl-4-methylphenol |
|
| Accession: | CHEBI:34247
|
browse the term
|
| Definition: | A phenol that has formula C15H24O. |
| Synonyms: | related_synonym: | 2,6-Bis(1,1-dimethylethyl)-4-methylphenol; 2,6-Di-t-butyl-4-methylphenol; 2,6-Di-tert-butyl-1-hydroxy-4-methylbenzene; 2,6-Di-tert-butyl-4-cresol; 2,6-Di-tert-butyl-p-cresol; BHT; Butylated hydroxytoluene; Butylhydroxytoluene; C15H24O; Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C; InChI=1S/C15H24O/c1-10-8-11(14(2,3)4)13(16)12(9-10)15(5,6)7/h8-9,16H,1-7H3; InChIKey=NLZUEZXRPGMBCV-UHFFFAOYSA-N |
| | xref_casrn: | 128-37-0 |
| | xref: | Beilstein:1911640 "Beilstein Registry Number"; ChEMBL:138581 "ChEMBL COMPOUND"; ChemIDplus:128-37-0 "CAS Registry Number"; KEGG COMPOUND:128-37-0 "CAS Registry Number"; KEGG COMPOUND:C14693 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D002084 |
|
|
2,6-di-tert-butyl-4-methylphenol
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Actg1 |
actin, gamma 1 |
|
increases expression |
EXP |
10 |
109,773,489 |
109,776,334 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Aifm2 |
apoptosis-inducing factor, mitochondrion-associated 2 |
|
multiple interactions |
EXP |
20 |
29,089,730 |
29,104,084 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
affects localization |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa2 |
apolipoprotein A-II |
|
multiple interactions |
ISO |
13 |
87,114,734 |
87,116,372 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
increases expression |
EXP |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
increases expression |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
multiple interactions |
ISO |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
multiple interactions |
ISO |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
C5 |
complement component 5 |
|
increases expression |
EXP |
3 |
14,011,115 |
14,102,744 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
decreases activity |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
affects expression |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Caprin1 |
cell cycle associated protein 1 |
|
increases expression |
ISO |
3 |
89,062,097 |
89,093,093 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccdc116 |
coiled-coil domain containing 116 |
|
increases expression |
ISO |
11 |
85,849,737 |
85,852,819 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
increases expression |
ISO |
19 |
10,641,376 |
10,642,827 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases secretion |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
increases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Cd19 |
CD19 molecule |
|
decreases expression |
ISO |
1 |
185,501,247 |
185,507,665 |
RGD:6480464 |
CTD |
| G |
Cd37 |
CD37 molecule |
|
decreases expression |
ISO |
1 |
95,709,961 |
95,715,116 |
RGD:6480464 |
CTD |
| G |
Cd3d |
CD3 molecule, delta |
|
decreases expression |
ISO |
8 |
47,932,151 |
47,936,744 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
multiple interactions |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd81 |
Cd81 molecule |
|
increases expression |
EXP |
1 |
203,327,287 |
203,342,901 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
|
increases expression |
EXP |
1 |
206,681,430 |
206,683,098 |
RGD:6480464 |
CTD |
| G |
Cfi |
complement factor I |
|
increases expression |
ISO |
2 |
227,281,621 |
227,325,109 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
increases expression |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
increases expression |
ISO |
X |
127,538,685 |
127,549,019 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
increases expression |
ISO |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Cox6b2 |
cytochrome c oxidase subunit VIb polypeptide 2 |
|
increases expression |
ISO |
1 |
67,810,527 |
67,811,752 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
increases expression |
EXP |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases expression |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Dcx |
doublecortin |
|
multiple interactions |
EXP |
X |
34,596,262 |
34,672,383 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
multiple interactions |
EXP |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
increases expression |
ISO |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dock2 |
dedicator of cytokinesis 2 |
|
decreases expression |
ISO |
10 |
19,207,499 |
19,660,353 |
RGD:6480464 |
CTD |
| G |
Elavl1 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
affects localization |
ISO |
12 |
1,459,046 |
1,500,042 |
RGD:6480464 |
CTD |
| G |
Eln |
elastin |
|
multiple interactions |
ISO |
12 |
23,033,657 |
23,077,043 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
increases expression |
ISO |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Ereg |
epiregulin |
|
increases expression |
ISO |
14 |
18,521,069 |
18,534,844 |
RGD:6480464 |
CTD |
| G |
Evpl |
envoplakin |
|
increases expression |
ISO |
10 |
106,336,953 |
106,353,217 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
multiple interactions |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
affects response to substance |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
affects localization |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
increases expression |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
increases expression |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
increases expression |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
affects response to substance |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
increases expression |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gfpt2 |
glutamine-fructose-6-phosphate transaminase 2 |
|
increases expression |
ISO |
10 |
35,290,139 |
35,336,286 |
RGD:6480464 |
CTD |
| G |
Ggta1 |
glycoprotein, alpha-galactosyltransferase 1 |
|
increases expression |
ISO |
3 |
14,485,028 |
14,559,484 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases phosphorylation |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases phosphorylation |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
increases expression |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
increases expression |
EXP |
17 |
47,145,567 |
47,188,345 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
multiple interactions |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
increases activity |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gzma |
granzyme A |
|
decreases expression |
ISO |
2 |
44,488,295 |
44,500,128 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
affects expression |
EXP |
3 |
143,447,697 |
143,490,281 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
increases expression |
ISO |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Hexb |
hexosaminidase B |
|
multiple interactions |
EXP |
2 |
27,649,188 |
27,672,231 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases activity |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
affects expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf1a |
HNF1 homeobox A |
|
multiple interactions |
ISO |
12 |
42,919,574 |
42,945,670 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
affects localization |
ISO |
7 |
142,150,229 |
142,154,520 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
multiple interactions |
ISO |
7 |
142,150,229 |
142,154,520 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
increases expression |
ISO |
7 |
142,150,229 |
142,154,520 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
multiple interactions |
ISO |
4 |
79,700,327 |
79,704,116 |
RGD:6480464 |
CTD |
| G |
Hnrpd |
heterogeneous nuclear ribonucleoprotein D |
|
affects localization |
ISO |
14 |
10,917,674 |
10,935,989 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
decreases methylation |
EXP |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
increases response to substance |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
ISO |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il15 |
interleukin 15 |
|
affects expression |
EXP |
19 |
27,487,268 |
27,498,973 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
increases expression |
ISO |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Ilk |
integrin-linked kinase |
|
multiple interactions |
ISO |
1 |
163,481,299 |
163,487,550 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
increases expression |
ISO |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
increases mutagenesis |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
multiple interactions |
ISO |
2 |
228,550,263 |
228,673,131 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
multiple interactions |
EXP |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
increases expression |
ISO |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mcm3 |
minichromosome maintenance complex component 3 |
|
increases expression |
ISO |
9 |
19,536,922 |
19,554,871 |
RGD:6480464 |
CTD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
multiple interactions |
ISO |
MT |
7,006 |
7,689 |
RGD:6480464 |
CTD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
multiple interactions |
ISO |
MT |
7,006 |
7,689 |
RGD:6480464 |
CTD |
| G |
Myl3 |
myosin, light chain 3, alkali; ventricular, skeletal, slow |
|
increases expression |
ISO |
8 |
115,140,705 |
115,146,827 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases activity |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
multiple interactions |
ISO |
1 |
95,027,197 |
95,032,516 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
multiple interactions |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nras |
neuroblastoma ras oncogene |
|
increases activity |
EXP |
2 |
198,292,650 |
198,300,286 |
RGD:6480464 |
CTD |
| G |
Nrbf2 |
nuclear receptor binding factor 2 |
|
increases expression |
EXP |
20 |
22,128,235 |
22,146,505 |
RGD:6480464 |
CTD |
| G |
Nup54 |
nucleoporin 54 |
|
increases expression |
ISO |
14 |
17,178,761 |
17,197,062 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
multiple interactions |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Parn |
poly(A)-specific ribonuclease |
|
decreases expression |
ISO |
10 |
1,788,754 |
1,925,032 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
increases expression |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
multiple interactions |
ISO |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Phex |
phosphate regulating endopeptidase homolog, X-linked |
|
increases expression |
ISO |
X |
58,911,144 |
59,168,857 |
RGD:6480464 |
CTD |
| G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
|
increases expression |
ISO |
10 |
55,227,872 |
55,248,301 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Pomp |
proteasome maturation protein |
|
increases expression |
EXP |
12 |
7,719,721 |
7,732,544 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
multiple interactions |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
multiple interactions |
ISO |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
multiple interactions |
EXP |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Pou2f1 |
POU class 2 homeobox 1 |
|
decreases expression |
ISO |
13 |
81,607,326 |
81,739,958 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
decreases expression |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
multiple interactions |
ISO |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
multiple interactions |
ISO |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
multiple interactions |
ISO |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases expression |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pthlh |
parathyroid hormone-like hormone |
|
increases expression |
ISO |
4 |
184,887,702 |
184,898,841 |
RGD:6480464 |
CTD |
| G |
Rab31 |
RAB31, member RAS oncogene family |
|
decreases expression |
ISO |
9 |
104,408,546 |
104,543,084 |
RGD:6480464 |
CTD |
| G |
Rad21 |
RAD21 homolog (S. pombe) |
|
increases expression |
ISO |
7 |
88,267,648 |
88,294,703 |
RGD:6480464 |
CTD |
| G |
Rad51ap1 |
RAD51 associated protein 1 |
|
increases expression |
ISO |
4 |
163,308,788 |
163,321,854 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rif1 |
RAP1 interacting factor homolog (yeast) |
|
increases expression |
ISO |
3 |
33,574,934 |
33,624,794 |
RGD:6480464 |
CTD |
| G |
Rnf112 |
ring finger protein 112 |
|
affects expression |
EXP |
10 |
47,599,958 |
47,605,503 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin L |
|
decreases expression |
ISO |
13 |
79,827,342 |
79,845,296 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
increases expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Shisa2 |
shisa homolog 2 (Xenopus laevis) |
|
decreases expression |
ISO |
15 |
38,740,511 |
38,744,809 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
increases expression |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
decreases expression |
ISO |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Slc39a11 |
solute carrier family 39 (metal ion transporter), member 11 |
|
increases expression |
ISO |
10 |
102,863,399 |
103,189,081 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spib |
Spi-B transcription factor (Spi-1/PU.1 related) |
|
decreases expression |
ISO |
1 |
95,004,163 |
95,009,998 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Srsf1 |
serine/arginine-rich splicing factor 1 |
|
multiple interactions |
ISO |
10 |
76,339,824 |
76,344,552 |
RGD:6480464 |
CTD |
| G |
Srsf1 |
serine/arginine-rich splicing factor 1 |
|
affects localization |
ISO |
10 |
76,339,824 |
76,344,552 |
RGD:6480464 |
CTD |
| G |
Srsf1 |
serine/arginine-rich splicing factor 1 |
|
increases expression |
ISO |
10 |
76,339,824 |
76,344,552 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
ISO |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Stom |
stomatin |
|
increases expression |
ISO |
3 |
14,392,978 |
14,415,288 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tdo2 |
tryptophan 2,3-dioxygenase |
|
affects expression |
EXP |
2 |
173,594,020 |
173,611,833 |
RGD:6480464 |
CTD |
| G |
Tdo2 |
tryptophan 2,3-dioxygenase |
|
increases expression |
ISO |
2 |
173,594,020 |
173,611,833 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
multiple interactions |
ISO |
20 |
18,100,629 |
18,112,682 |
RGD:6480464 |
CTD |
| G |
Tfb1m |
transcription factor B1, mitochondrial |
|
multiple interactions |
ISO |
1 |
38,513,709 |
38,556,210 |
RGD:6480464 |
CTD |
| G |
Tfb2m |
transcription factor B2, mitochondrial |
|
multiple interactions |
ISO |
13 |
95,228,520 |
95,246,255 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
decreases response to substance |
EXP |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Thpo |
thrombopoietin |
|
multiple interactions |
ISO |
11 |
82,412,552 |
82,417,807 |
RGD:6480464 |
CTD |
| G |
Tmem45b |
transmembrane protein 45b |
|
decreases expression |
ISO |
8 |
31,178,178 |
31,223,722 |
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
increases expression |
EXP |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
|
increases expression |
ISO |
20 |
11,367,545 |
11,389,283 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
Term paths to the root
|